Regulus Therapeutics
RGLS
#6919
Rank
NZ$0.96 B
Marketcap
NZ$13.95
Share price
0.00%
Change (1 day)
434.74%
Change (1 year)

Market capitalization of Regulus Therapeutics (RGLS)

Last known market cap: NZ$0.96 Billion

On August 27, 2025 Regulus Therapeutics had a market cap of NZ$0.96 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Regulus Therapeutics from 2012 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$0.97 B445.4%
2024NZ$0.17 B336.97%
2023NZ$40.93 M12.64%
2022NZ$36.33 M-46.02%
2021NZ$67.31 M-43.34%
2020NZ$0.11 B327.77%
2019NZ$27.77 M127.05%
2018NZ$12.23 M-91.96%
2017NZ$0.15 B-11.45%
2016NZ$0.17 B-74.38%
2015NZ$0.67 B-33.03%
2014NZ$1.00 B166.64%
2013NZ$0.37 B36.94%
2012NZ$0.27 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Sanofi
SNY
NZ$181.20 B 18,655.92%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
NZ$45.65 B 4,625.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$206.44 B 21,268.64%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$503.74 B 52,040.77%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
NZ$179.80 B 18,511.50%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sangamo Therapeutics
SGMO
NZ$0.23 B-75.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
NZ$5.09 B 427.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$72.19 B 7,372.63%๐Ÿ‡บ๐Ÿ‡ธ USA